In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kipchu Tshering, Mir Misbahuddin
Format: Artigo
Jezik:Inglês
Izdano: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Serija:Bangabandhu Sheikh Mujib Medical University Journal
Teme:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Online pristup:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items